Pfizer, GSK, others face negligence suits over Zantac carcinogen testing

23rd October 2019 Uncategorised 0

Drugmakers are scrambling to pull Zantac off the shelves after a possible carcinogen was found in the heartburn med’s API. Now, a suite of federal lawsuits are claiming four companies declined to test their versions of the drug for the compound.

More: Pfizer, GSK, others face negligence suits over Zantac carcinogen testing
Source: fierce